InsiderSignalSign in
← Insider buys

FGEN

Fibrogen Inc · HEALTHCARE

Insiders bought $34K of Fibrogen Inc in the last 12 months

1 insider bought on 1 day.

$34KBought, 12 mo
$0Sold, 12 mo
Follow FGEN

FGEN over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

FGEN after insider buys

3 months after each buy, from the first price a copier could get.

−0.6%Average
−6.7 ptsVs S&P 500
1 of 4Higher

4 buys since 2017 with 3 months of prices.

Every filing

295 insider filings since 2016, newest first

FGENSell

Thomas F Kearns Jr · Director

$417K−7.0%Mar 23
FGENSell

Christine Chung · SVP, China Operations

$287K−7.0%Mar 19
FGENSell

Pat Cotroneo · SVP, Finance, CFO

$244K−3.0%Mar 18
FGENSell

Christine Chung · SVP, China Operations

$509K−8.0%Feb 13
FGENSell

Kalevi Kurkijarvi · Director

$256K−17.0%Feb 12
FGENSell

Kalevi Kurkijarvi · Director

$256K−17.0%Jan 8
FGENSell

Christine Chung · SVP, China Operations

$482K−8.0%Jan 8
FGENSell

Pat Cotroneo · SVP, Finance, CFO

$2.7M−19.0%Dec 26
FGENSell

Christine Chung · SVP, China Operations

$529K−8.0%Dec 18
FGENSell

K Peony Yu · Chief Medical Officer

$160K−2.0%Dec 17
FGENSell

Kalevi Kurkijarvi · Director

$285K−17.0%Dec 12
FGENSell

Christine Chung · SVP, China Operations

$390K−7.0%Nov 15
FGENSell

Kalevi Kurkijarvi · Director

$230K−17.0%Nov 8
FGENSell

Christine Chung · SVP, China Operations

$413K−7.0%Oct 10
FGENSell

Kalevi Kurkijarvi · Director

$220K−17.0%Oct 9
FGENSell

Christine Chung · SVP, China Operations

$452K−7.0%Sep 23
FGENSell

K Peony Yu · Chief Medical Officer

$140K−2.0%Sep 18
FGENSell

Pat Cotroneo · SVP, Finance, CFO

$132K−1.0%Sep 18
FGENSell

Kalevi Kurkijarvi · Director

$246K−17.0%Sep 10
FGENSell

Christine Chung · SVP, China Operations

$486K−7.0%Aug 26
FGENSell

Thomas B Neff · CEO

$1.8M−2.0%Aug 23
FGENSell

Thomas B Neff · CEO

$1.8M−2.0%Aug 14
FGENSell

Kalevi Kurkijarvi · Director

$271K−17.0%Aug 7
FGENSell

Thomas B Neff · CEO

$1.9M−2.0%Jul 26
FGENSell

Thomas B Neff · CEO

$1.8M−2.0%Jul 12
FGENSell

Christine Chung · SVP, China Operations

$506K−7.0%Jul 12
FGENSell

Kalevi Kurkijarvi · Director

$256K−17.0%Jul 10
FGENSell

Elias Kouchakji · SVP, Clinical Dev, Drug Safety

$129K−3.0%Jul 2
FGENSell

Thomas B Neff · CEO

$1.8M−2.0%Jun 21
FGENSell

Pat Cotroneo · SVP, Finance, CFO

$138K−1.0%Jun 20
FGENSell

Christine Chung · SVP, China Operations

$496K−7.0%Jun 20
FGENSell

K Peony Yu · Chief Medical Officer

$140K−2.0%Jun 14
FGENSell

Thomas B Neff · CEO

$1.5M−2.0%Jun 7
FGENSell

Kalevi Kurkijarvi · Director

$227K−17.0%Jun 7
FGENSell

Thomas B Neff · CEO

$1.4M−1.0%May 24
FGENSell

Thomas B Neff · CEO

$1.4M−1.0%May 15
FGENSell

Kalevi Kurkijarvi · Director

$276K−20.0%May 10
FGENSell

Christine Chung · SVP, China Operations

$522K−7.0%May 9
FGENSell

James A Schoeneck · Director

$94K−7.0%May 9
FGENSell

Thomas B Neff · CEO

$1.9M−1.0%Apr 19
FGENSell

Kalevi Kurkijarvi · Director

$192K−14.0%Apr 17
FGENSell

James A Schoeneck · Director

$106K−7.0%Apr 10
FGENSell

Kalevi Kurkijarvi · Director

$212K−14.0%Apr 10
FGENSell

Thomas B Neff · CEO

$2.1M−1.0%Apr 5
FGENSell

Thomas B Neff · CEO

$2.2M−1.0%Mar 22
FGENSell

Pat Cotroneo · SVP, Finance, CFO

$425K−3.0%Mar 20
FGENSell

K Peony Yu · Chief Medical Officer

$515K−5.0%Mar 15
FGENSell

James A Schoeneck · Director

$109K−7.0%Mar 8
FGENSell

Thomas B Neff · CEO

$2.2M−1.0%Mar 8
FGENSell

Pat Cotroneo · SVP, Finance, CFO

$888K−6.0%Mar 1
Newer filingsOlder filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.